Innocoll Biotherapeutics

Innocoll Biotherapeutics company information, Employees & Contact Information

Explore related pages

Innocoll Biotherapeutics email format Innocoll Biotherapeutics management contacts

Related company profiles:

Innocoll is committed to improving patient care by confronting some of today’s most important healthcare challenges. Everyone at Innocoll is united by a common goal: to deliver healthcare solutions that make a difference in patients’ lives. We take pride in fostering a culture of collaboration, and we strive to be the best possible partners to the hospitals and doctors we support. Our current late-stage product pipeline, including XARACOLL (bupivacaine HCl) implant and POSIMIR (bupivacaine solution) for infiltration use, are focused on addressing patient needs for postsurgical pain management.

Company Details

Employees
19
Founded
-
Address
210 Carnegie Center, 103,germany
Phone
(484) 406-5200
Email
bu****@****inc.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
innocoll.com
Keywords
Pharmaceutical, Targeted Drug Delivery, Collagen-based Technologies, Medical Device.
HQ
Princeton, New Jersey
Competitors
Abzena, Teleflex, Kerecis, AstraZeneca, Advanced Medical Solutions, Corius Tissue Regeneration, Pacira BioSciences, Inc., Syntacoll GmbH, Deep Blue Medical Advances, Inc., Medtronic.
Looking for a particular Innocoll Biotherapeutics employee's phone or email?

Innocoll Biotherapeutics Questions

News

Innocoll Biotherapeutics plc Announces First Patients In Phase 3 Clinical Trials for Label Expansion of Xaracoll® (bupivacaine hydrochloride) Implant - Business Wire

Innocoll Biotherapeutics plc Announces First Patients In Phase 3 Clinical Trials for Label Expansion of Xaracoll® (bupivacaine hydrochloride) Implant Business Wire

Innocoll Announces Commercial Launch of XARACOLL® (bupivacaine HCI) implant, a Non-opioid, Drug-device Treatment Option for Acute Postsurgical Pain Relief for up to 24 Hours Following Open Inguinal Hernia Repair in Adults - PR Newswire

Innocoll Announces Commercial Launch of XARACOLL® (bupivacaine HCI) implant, a Non-opioid, Drug-device Treatment Option for Acute Postsurgical Pain Relief for up to 24 Hours Following Open Inguinal Hernia Repair in Adults PR Newswire

Latham Advises Innocoll Biotherapeutics in US$125 Million Term Loan with Leading Biotech Investor Oaktree Capital - Latham & Watkins LLP

Latham Advises Innocoll Biotherapeutics in US$125 Million Term Loan with Leading Biotech Investor Oaktree Capital Latham & Watkins LLP

XaraColl Implant Approved for Postop Pain Following Hernia Repair - Medical Professionals Reference

XaraColl Implant Approved for Postop Pain Following Hernia Repair Medical Professionals Reference

Innocoll Holdings Ltd. Appoints Kimball Hall as Chief Executive Officer - Business Wire

Innocoll Holdings Ltd. Appoints Kimball Hall as Chief Executive Officer Business Wire

Innocoll stock slides 65 percent after FDA setback for pain treatment - FirstWord Pharma

Innocoll stock slides 65 percent after FDA setback for pain treatment FirstWord Pharma

Innocoll crushed after PhIII diabetic foot infection flop - Fierce Biotech

Innocoll crushed after PhIII diabetic foot infection flop Fierce Biotech

Anthony Galdi Appointed Chief Commercial Officer of Innocoll - BioSpace

Anthony Galdi Appointed Chief Commercial Officer of Innocoll BioSpace

FDA Approves XARACOLL® (bupivacaine HCl) Implant, a Non-opioid, Drug-device Treatment Option for Acute Postsurgical Pain Relief for up to 24 Hours Following Open Inguinal Hernia Repair in Adults - PR Newswire

FDA Approves XARACOLL® (bupivacaine HCl) Implant, a Non-opioid, Drug-device Treatment Option for Acute Postsurgical Pain Relief for up to 24 Hours Following Open Inguinal Hernia Repair in Adults PR Newswire

Innocoll Announces Successful Completion of Debt Refinancing - Business Wire

Innocoll Announces Successful Completion of Debt Refinancing Business Wire

Louis Pascarella Appointed Chief Executive Officer of Innocoll - Business Wire

Louis Pascarella Appointed Chief Executive Officer of Innocoll Business Wire

Here’s What Just Happened With Innocoll Holdings plc (NASDAQ:INNL) and NewLink Genetics Corporation (NASDAQ:NLNK) - marketexclusive.com

Here’s What Just Happened With Innocoll Holdings plc (NASDAQ:INNL) and NewLink Genetics Corporation (NASDAQ:NLNK) marketexclusive.com

Companies like Innocoll Biotherapeutics

Medtronic logo - Similar company to Innocoll Biotherapeutics

Medtronic

97.72K
Corius Tissue Regeneration logo - Similar company to Innocoll Biotherapeutics

Corius Tissue Regene...

NA
Abzena logo - Similar company to Innocoll Biotherapeutics

Abzena

428
Teleflex logo - Similar company to Innocoll Biotherapeutics

Teleflex

9.43K
Kerecis logo - Similar company to Innocoll Biotherapeutics

Kerecis

522
Pacira BioSciences, Inc. logo - Similar company to Innocoll Biotherapeutics

Pacira Biosciences, ...

858
Deep Blue Medical Advances, Inc. logo - Similar company to Innocoll Biotherapeutics

Deep Blue Medical Ad...

10
Advanced Medical Solutions logo - Similar company to Innocoll Biotherapeutics

Advanced Medical Sol...

429
AstraZeneca logo - Similar company to Innocoll Biotherapeutics

Astrazeneca

78.61K
Syntacoll GmbH logo - Similar company to Innocoll Biotherapeutics

Syntacoll Gmbh

27

Top Innocoll Biotherapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant